(Q44592616)

English

Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron

scientific article published in October 2003

Statements

Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron (English)
1 October 2003
1570-1577

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit